Joe Hennessey, THE MONITOR DAILY
(The Monitor Daily) — A study published in the Science journal on Friday by a mixed team showcased the results of an experimental vaccine which seems to be on track of providing a safeguard against the spread of HIV, representing one of the biggest steps forward in this regard in history.
The HIV vaccine, developed by a combined team from The Rockefeller University, The Scrips Research Institute(TSRI) and the International AIDS Vaccine Initiative (IAVI) has had satisfactory results after being tested on mice, with its goal being to stimulate the production antibodies needed to stop or prevent HIV infection. The research was led by a trio consisting of TSRI Department of Immunology chair Dennis Burton, IAVI Director of Vaccine Design William Schief and Professor David Nemazee of TSRI.
###